FBT First Trust NYSE Arca Biotechnology Index Fund

36

NYSE ARCA | ETF

Price
$161.84
Increased by +0.33%
Dollar volume (20D)
2.80 M
ADR%
1.25
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.

The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Top 20 Holdings

Asset Name Sector Industry Weight
ACAD ACADIA Pharmaceuticals Inc Healthcare Biotechnology 4.89%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 4.67%
NBIX Neurocrine Biosciences Inc Healthcare Drug Manufacturers - Specialty & Generic 4.39%
ALNY Alnylam Pharmaceuticals Inc Healthcare Biotechnology 4.18%
RARE Ultragenyx Healthcare Biotechnology 4.00%
EXEL Exelixis Inc Healthcare Biotechnology 3.90%
ILMN Illumina Inc Healthcare Diagnostics & Research 3.84%
INCY Incyte Corporation Healthcare Biotechnology 3.75%
EXAS EXACT Sciences Corporation Healthcare Diagnostics & Research 3.75%
QGEN Qiagen NV Healthcare Diagnostics & Research 3.65%
NTRA Natera Inc Healthcare Diagnostics & Research 3.65%
CPRX Catalyst Pharmaceuticals Inc Healthcare Biotechnology 3.58%
IQV IQVIA Holdings Inc Healthcare Diagnostics & Research 3.55%
BGNE BeiGene Ltd Healthcare Biotechnology 3.55%
MTD Mettler-Toledo International Inc Healthcare Diagnostics & Research 3.54%
GMAB Genmab AS Healthcare Biotechnology 3.49%
ALKS Alkermes Plc Healthcare Drug Manufacturers - Specialty & Generic 3.44%
BIIB Biogen Inc Healthcare Drug Manufacturers - General 3.44%
CORT Corcept Therapeutics Incorporated Healthcare Biotechnology 3.43%
CRL Charles River Laboratories Healthcare Diagnostics & Research 3.41%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY